Clinical Trial Update: Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating carboplatin and etoposide in combination with LBH589 (panobinostat) for small cell lung cancer was terminated. The study was sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• LBH589 (panobinostat)

Snippet

Sponsor: Ahmad Tarhini | Conditions: Small Cell Lung Cancer | Phase 1 | Status: TERMINATED